Save The Date! 2/22/18: The Jaharis Symposium on Health Law and Intellectual Property

On February 22, 2018, join DePaul University, located in downtown Chicago, for The Jaharis Symposium on Health Law and Intellectual Property: Technological and Emergency Responses to Pandemic Diseases.

Hosted by DePaul University’s Mary and Michael Jaharis Health Law Institute and the Center for Intellectual Property Law and Information Technology (CIPLIT®), this one day conference will focus on “best practices” in response to emerging pandemic diseases.

Connect with keynote speakers Lawrence Gostin–University Professor and Faculty Director, O’Neill Institute for National and Global Health Law, Georgetown University– and Richard Wilder–Associate General Counsel, Global Health Program, Bill and Melinda Gates Foundation.  They will be joined by other esteemed panelists during this timely and important discussion.


This entry was posted in Bioethics, Biotechnology, Events, Health Law Policy, Pharmaceuticals, Public Health, Wendy Netter Epstein by Wendy Netter Epstein. Bookmark the permalink.

About Wendy Netter Epstein

Wendy Netter Epstein is a Visiting Associate Professor at the University Chicago Law School, and an Associate Professor of Law and Faculty Director of the Jaharis Health Law Institute at the DePaul University College of Law. She is a graduate of Harvard Law School, where she was editor-in-chief of the Journal of Law, Medicine & Ethics, Recent Developments. Prior to starting her academic career, Professor Epstein was a partner in commercial litigation at Kirkland & Ellis LLP, with a focus on health industry clients. Professor Epstein’s teaching and research interests focus on health care law and policy, contracts, and commercial law. Her work takes an interdisciplinary approach, applying both law and economics and behavioral science principles to problems negatively impacting vulnerable parties. In 2017, Professor Epstein won both the University-wide and law school Excellence in Teaching Awards at DePaul University. Representative publications: The Health Insurer Nudge, 91 S. Cal. L. Rev. (forthcoming 2018). Price Transparency and Incomplete Contracts in Health Care, 67 Emory L. J. (forthcoming 2017). Nudging Patient Decision-Making, 91 Wash. L. Rev. (forthcoming 2017). Revisiting Incentive-Based Contracts, 17 Yale J. Health Pol’y L. & Ethics 1 (2017). Facilitating Incomplete Contracts, 65 Case W. Res. L. Rev. 297 (2015). Public-Private Contracting and the Reciprocity Norm, 64 Am. U. L. Rev. 1 (2014). Contract Theory and the Failures of Public-Private Contracting, 34 Cardozo L. Rev. 2211 (2013).